Takeda Pharmaceutical Company Limited
CELL PRODUCTION METHOD
Last updated:
Abstract:
An object of the present invention is to provide a novel approach that enables definitive endoderm cells or insulin-producing cells to be efficiently induced and/or manufactured from pluripotent stem cells. The present invention provides a method for producing definitive endoderm cells from pluripotent stem cells, comprising subjecting pluripotent stem cells to first culture in a differentiation-inducing medium in which insulin acts and subsequently to second culture in a differentiation-inducing medium in which insulin does not act.
Status:
Application
Type:
Utility
Filling date:
2 Aug 2019
Issue date:
23 Sep 2021